Role of new biomarkers: Functional and structural damage

Critical Care Research and Practice

Volumn 2013, Issue , 2013, Pages

  Tsigou, Evdoxia ^a   Psallida, Vasiliki ^a   Demponeras, Christos ^a   Boutzouka, Eleni ^a   Baltopoulos, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874589445     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2013/361078     Document Type: Review

References (103)

1. Bellomo R., Ronco C., Kellum J. A., Mehta R. L., Palevsky P., Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004 8 4 R204 212 2-s2.0-10244236377
2. Mehta R. L., Kellum J. A., Shah S. V., Molitoris B. A., Ronco C., Warnock D. G., Levin A., Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007 11 2 R31 2-s2.0-34447249446
3. Ympa Y. P., Sakr Y., Reinhart K., Vincent J. L., Has mortality from acute renal failure decreased? A systematic review of the literature. American Journal of Medicine 2005 118 8 827 832 2-s2.0-23244440521 10.1016/j.amjmed.2005. 01.069 (Pubitemid 41097456)
4. Moore E., Bellomo R., Nichol A., Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiologica 2010 76 6 425 440 2-s2.0-77954981818
5. Devarajan P., Emerging biomarkers of acute kidney injury. Contributions to Nephrology 2007 156 203 212
6. Bagshaw S. M., Gibney R. T. N., Conventional markers of kidney function. Critical Care Medicine 2008 36 supplement 4 S152 S158 10.1097/CCM. 0b013e318168c613 (Pubitemid 351483045)
7. Uchino S., Creatinine. Current Opinion in Critical Care 2010 16 562 567 10.1097/MCC.0b013e32833ea7f3
8. Stevens L. A., Levey A. S., Measurement of kidney function. Medical Clinics of North America 2005 89 3 457 473 10.1016/j.mcna.2004.11.009 (Pubitemid 40332392)
9. Mishra J., Dent C., Tarabishi R., Mitsnefes M. M., Ma Q., Kelly C., Ruff S. M., Zahedi K., Shao M., Bean J., Mori K., Barasch J., Devarajan P., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. The Lancet 2005 365 9466 1231 1238 2-s2.0-20144388328 10.1016/S0140-6736(05)74811-X (Pubitemid 40469655)
10. Wagener G., Jan M., Kim M., Mori K., Barasch J. M., Sladen R. N., Lee H. T., Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006 105 3 485 491 2-s2.0-33748127615 10.1097/00000542-200609000- 00011 (Pubitemid 44310430)
11. Dent C. L., Ma Q., Dastrala S., Bennett M., Mitsnefes M. M., Barasch J., Devarajan P., Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Critical Care 2007 11 6, article R127 2-s2.0-38349195608 10.1186/cc6192
12. Wagener G., Gubitosa G., Wang S., Borregaard N., Kim M., Lee H. T., Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. American Journal of Kidney Diseases 2008 52 3 425 433 2-s2.0-49749100773 10.1053/j.ajkd.2008.05.018
13. Bennett M., Dent C. L., Ma Q., Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin Journal of the American Society of Nephrology 2008 3 665 673 10.2215/CJN.04010907
14. Xin C., Yulong X., Yu C., Changchun C., Feng Z., Xinwei M., Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Renal Failure 2008 30 9 904 913 2-s2.0-54249113958 10.1080/08860220802359089
15. Koyner J. L., Bennett M. R., Worcester E. M., Ma Q., Raman J., Jeevanandam V., Kasza K. E., O'Connor M. F., Konczal D. J., Trevino S., Devarajan P., Murray P. T., Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney International 2008 74 8 1059 1069 2-s2.0-53049105507 10.1038/ki.2008.341
16. Tuladhar S. M., Puntmann V. O., Soni M., Punjabi P., Bogle L., Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. Journal of Cardiovascular Pharmacology 2009 53 261 266 10.1097/FJC.0b013e31819d6139
17. Haase-Fielitz A., Bellomo R., Devarajan P., Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery: a prospective cohort study. Critical Care Medicine 2009 37 553 560 10.1097/CCM.0b013e318195846e
18. Che M., Xie B., Xue S., Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron Clinical Practice 2010 115 c66 c72 10.1159/000286352
19. Prabhu A., Sujatha D. I., Ninan B., Vijayalakshmi M. A., Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Annals of Vascular Surgery 2010 24 4 525 531 2-s2.0-77951666610 10.1016/j.avsg.2010.01.001
20. Perry T. E., Muehlschlegel J. D., Liu K. Y., Fox A. A., Collard C. D., Shernan S. K., Body S. C., Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesthesia and Analgesia 2010 110 6 1541 1547 2-s2.0-77953222539 10.1213/ANE.0b013e3181da938e
21. Krawczeski C., Goldstein S., Woo J., Wang Y., Piyaphanee N., Ma Q., Bennett M., Devarajan P., Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. American College of Cardiology Foundation 2011 58 22 2301 2309
22. Parikh C., Coca S., Thiessen-Philbrook H., Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. Journal of the American Society of Nephrology 2011 22 1748 1757 10.1681/ASN.2010121302
23. Fadel F., Abdel Rahman A., Mohamed M. F., Habib S., Ibrahim M., Sleem Z., Bazaraa H., Soliman M., Plasma neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury after cardio-pulmonary bypass in pediatric cardiac surgery. Archives of Medical Science 2012 8 2 250 255
24. Liu S., Che M., Xue S., Xie B., Zhu M., Lu R., Zhang W., Qian J., Yan Y., Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients. Biomarkers 2012 18 1 95 101 10.3109/1354750X.2012.740687
25. Zappitelli M., Washburn K. K., Arikan A. A., Loftis L., Ma Q., Devarajan P., Parikh C. R., Goldstein S. L., Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Critical Care 2007 11, article R84 2-s2.0-34547863206 10.1186/cc6089 (Pubitemid 47262102)
26. Wheeler D. S., Devarajan P., Ma Q., Harmon K., Monaco M., Cvijanovich N., Wong H. R., Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Critical Care Medicine 2008 36 4 1297 1303 2-s2.0-41649097463 10.1097/CCM. 0b013e318169245a (Pubitemid 351482681)
27. Makris K., Markou N., Evodia E., Dimopoulou E., Drakopoulos I., Ntetsika K., Rizos D., Baltopoulos G., Haliassos A., Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clinical Chemistry and Laboratory Medicine 2009 47 1 79 82 2-s2.0-58149252132 10.1515/CCLM.2009.004
28. Siew E. D., Ware L. B., Gebretsadik T., Shintani A., Moons K. G. M., Wickersham N., Bossert F., Ikizler T. A., Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. Journal of the American Society of Nephrology 2009 20 8 1823 1832 2-s2.0-68049135322 10.1681/ASN.2008070673
29. Little K., Noland B., Kupfer K., Measurement of admission neutrophil gelatinase-associated lipocalin value for risk assessment of severe acute kidney injury in an adult heterogeneous ICU population. NDT Plus 2009 2 supplement 2 ii 842
30. Cruz D. N., de Cal M., Garzotto F., Perazella M. A., Lentini P., Corradi V., Piccinni P., Ronco C., Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Medicine 2010 36 3 444 451 2-s2.0-77951208845 10.1007/s00134-009-1711-1
31. Shapiro N. I., Trzeciak S., Hollander J. E., Birkhahn R., Otero R., Osborn T. M., Moretti E., Nguyen H. B., Gunnerson K., Milzman D., Gaieski D. F., Goyal M., Cairns C. B., Kupfer K., Lee S. W., Rivers E. P., The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Annals of Emergency Medicine 2010 56 1 52 59 2-s2.0-77953560654 10.1016/j.annemergmed.2010.02.010
32. Mårtensson J., Bell M., Oldner A., Xu S., Venge P., Martling C. R., Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Medicine 2010 36 8 1333 1340 2-s2.0-77956171921 10.1007/s00134-010-1887-4
33. Constantin J. M., Futier E., Perbet S., Roszyk L., Lautrette A., Gillart T., Guerin R., Jabaudon M., Souweine B., Bazin J. E., Sapin V., Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. Journal of Critical Care 2010 25 1 176.e1 176.e6 2-s2.0-77049122967 10.1016/j.jcrc.2009.05. 010
34. de Geus H., Bakker J., Lesaffre E., le Noble J., Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. American Journal of Respiratory and Critical Care Medicine 2011 183 907 914 10.1164/rccm.200908-1214OC
35. Royakkers A., Bouman C., Stassen P., Systemic and urinary neutrophil gelatinase-associated lipocalins are poor predictors of acute kidney injury in unselected critically Ill patients. Critical Care Research and Practice 2012 2012 8 10.1155/2012/712695 712695
36. Flower D. R., Experimentally determined lipocalin structures. Biochimica et Biophysica Acta 2000 1482 46 56 10.1016/S0167-4838(00)00147-3
37. Flo T. H., Smith K. D., Sato S., Rodriguez D. J., Holmes M. A., Strong R. K., Akira S., Aderem A., Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004 432 7019 917 921 2-s2.0-11144314814 10.1038/nature03104 (Pubitemid 40037155)
38. Cowland J. B., Borregaard N., Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997 45 1 17 23 2-s2.0-0031260224 10.1006/geno.1997.4896 (Pubitemid 27449379)
39. Mishra J., Qing M. A., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 2003 14 10 2534 2543 2-s2.0-0141678253 10.1097/01.ASN.0000088027.54400.C6 (Pubitemid 37169339)
40. Grigoryev D. N., Liu M., Hassoun H. T., Cheadle C., Barnes K. C., Rabb H., The local and systemic inflammatory transcriptome after acute kidney injury. Journal of the American Society of Nephrology 2008 19 3 547 558 2-s2.0-40449094520 10.1681/ASN.2007040469 (Pubitemid 351355398)
41. Makris K., Rizos D., Kafkas N., Haliassos A., Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clinical Chemistry and Laboratory Medicin 2012 50 9 1519 1532
42. Hirsch R., Dent C., Pfriem H., NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatric Nephrology 2007 22 2089 2095 10.1007/s00467-007-0601-4 (Pubitemid 350090716)
43. Mishra J., Mori K., Ma Q., Kellya C., Baraschb J., Devarajana P., Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. American Journal of Nephrology 2004 24 307 315 10.1159/000078452 (Pubitemid 39070114)
44. Mishra J., Mori K., Ma Q., Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. Journal of the American Society of Nephrology 2004 15 3073 3082 10.1097/01.ASN.0000145013.44578.45 (Pubitemid 39578839)
45. Schmidt-Ott K. M., Mori K., Li J. Y., Dual action of neutrophil gelatinase-associated Lipocalin. Journal of the American Society of Nephrology 2007 18 407 413 (Pubitemid 46193306)
46. Pedersen K. R., Ravn H. B., Hjortdal V. E., Nørregaard R., Povlsen J. V., Neutrophil Gelatinase-Associated Lipocalin (NGAL): validation of commercially available ELISA. Scandinavian Journal of Clinical and Laboratory Investigation 2010 70 5 374 382 2-s2.0-77956038866 10.3109/00365513.2010.486868
47. Cavalier E., Bekaert A. C., Carlisi A., Legrand D., Krzesinski J. M., Delanaye P., Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine 2011 49 2 339 341 2-s2.0-79952085859 10.1515/CCLM.2011.044
48. Grenier F. C., Ali S., Syed H., Workman R., Martens F., Liao M., Wang Y., Wong P. Y., Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clinical Biochemistry 2010 43 6 615 620 2-s2.0-77950858129 10.1016/j.clinbiochem.2009.12.008
49. Stejskal D., Karpíšek M., Humenanska V., Hanulova Z., Stejskal P., Kusnierova P., Petzel M., Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Hormone and Metabolic Research 2008 40 6 381 385 2-s2.0-47049118231 10.1055/s-2008-1062746 (Pubitemid 351967128)
50. Triage NGAL Test (REF 98400EU),. Biosite, Product insert, Inverness Medical, 2009
51. Urine NGAL (REF 1P37),. Product insert, Abbott Diagnostics Division, Longford, Ireland, 2009
52. Clerico A., Galli C., Fortunato A., Ronco C., Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clinical Chemistry and Laboratory Medicine 2012 50 9 1505 1517
53. Bagshaw S. M., Bellomo R., Devarajan P., Review article: acute kidney injury in critical illness. Canadian Journal of Anesthesia 2010 57 985 9998 10.1007/s12630-010-9375-4
54. Tuttle K. R., Worrall N. K., Dahlstrom L. R., Nandagopal R., Kausz A. T., Davis C. L., Predictors of ARF after cardiac surgical procedures. American Journal of Kidney Diseases 2003 41 1 76 83 2-s2.0-0037228392 10.1053/ajkd.2003.50025 (Pubitemid 36043353)
55. Haase M., Bellomo R., Haase-Fielitz A., Neutrophil gelatinase-associated lipocalin. Current Opinion in Critical Care 2010 16 526 532 10.1097/MCC. 0b013e328340063b
56. Bagshaw S. M., Bennett M., Haase M., Haase-Fielitz A., Egi M., Morimatsu H., D'Amico G., Goldsmith D., Devarajan P., Bellomo R., Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Medicine 2010 36 3 452 461 2-s2.0-77951208316 10.1007/s00134-009-1724-9
57. Haase-Fielitz A., Bellomo R., Devarajan P., Bennett M., Story D., Matalanis G., Frei U., Dragun D., Haase M., The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrology Dialysis Transplantation 2009 24 11 3349 3354 2-s2.0-73949148024 10.1093/ndt/gfp234
58. Nickolas T. L., O'Rourke M. J., Yang J., Sise M. E., Canetta P. A., Barasch N., Buchen C., Khan F., Mori K., Giglio J., Devarajan P., Barasch J., Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Annals of Internal Medicine 2008 148 11 810 819 2-s2.0-44649166336 (Pubitemid 351786928)
59. Parikh C. R., Jani A., Mishra J., Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. American Journal of Transplantation 2006 6 1639 1645 (Pubitemid 43945804)
60. Hall I. E., Yarlagadda S. G., Coca S. G., IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Journal of the American Society of Nephrology 2010 21 189 197 10.1681/ASN.2009030264
61. Haase M., Fielitz-Haase A., Bellomo R., Sodium bicarbonate to prevent acute kidney injury after cardiac surgery: a pilot double-blind, randomized controlled trial. Critical Care Medicine 2009 37 39 47 10.1097/CCM. 0b013e318193216f
62. Kümpers P., Hafer C., Lukasz A., Lichtinghagen R., Brand K., Fliser D., Faulhaber-Walter R., Kielstein J. T., Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Critical Care 2010 14 1, article R9 2-s2.0-77951460368 10.1186/cc8861
63. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009 54 6 1012 1024 2-s2.0-70449637194 10.1053/j.ajkd.2009.07.020
64. Bolignano D., Coppolino G., Donato V., Lacquanit A., Bono C., Buemi M., Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? Medical Science Monitor 2010 16 131 135
65. Devarajan P., Biomarkers for the early detection of acute kidney injury. Current Opinion in Pediatrics 2011 23 2 194 200 10.1097/MOP.0b013e328343f4dd
66. Seronie V., Cystatin C: current position and future prospects. Clinical Chemistry and Laboratory Medicine 2008 46 1664 1686
67. Croda-Todd M. T., Soto-Montano X. J., Hernández-Cancino P. A., Juárez-Aguilar E., Adult cystatin C reference intervals determined by nephelometric immunoassay. Clinical Biochemistry 2007 40 1084 1087 10.1016/j.clinbiochem.2007.05.011 (Pubitemid 47315713)
68. Trof R. J., di Maggio F., Leemreis J., Groeneveld A. B. J., Biomarkers of acute renal injury and renal failure. Shock 2006 26 3 245 253 2-s2.0-33747360138 10.1097/01.shk.0000225415.5969694.ce
69. Coca S. G., Yalavarthy R., Concato J., Parikh C. R., Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney International 2008 73 9 1008 1016 2-s2.0-42149105187 10.1038/sj.ki. 5002729 (Pubitemid 351543898)
70. Dharnidharka V. R., Kwon C., Stevens G., Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. American Journal of Kidney Diseases 2002 40 2 221 226 2-s2.0-0036329067 10.1053/ajkd.2002.34487 (Pubitemid 34827638)
71. Knight E. L., Verhave J. C., Spiegelman D., Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney International 2004 65 1416 1421 10.1111/j.1523-1755.2004. 00517.x (Pubitemid 38406982)
72. Herget-Rosenthal S., Marggraf G., Hüsing J., Göring F., Pietruck F., Janssen O., Philipp T., Kribben A., Early detection of acute renal failure by serum cystatin C. Kidney International 2004 66 3 1115 1122 2-s2.0-4344672550 10.1111/j.1523-1755.2004.00861.x (Pubitemid 39121017)
73. Nejat M., Pickering J. W., Walker R. J., Endre Z. H., Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrology Dialysis Transplantation 2010 25 3283 3289 10.1093/ndt/gfq176
74. Royakkers A. A. N. M., Korevaar J. C., van Suijlen J. D. E., Hofstra L. S., Kuiper M. A., Spronk P. E., Schultz M. J., Bouman C. S. C., Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Medicine 2011 37 3 493 501 2-s2.0-79953824981 10.1007/s00134-010-2087-y
75. Spahillari A., Parikh C. R., Sint K., Koyner J. L., Patel U. D., Edelstein C. L., Passik C. S., Thiessen-Philbrook H., Swaminathan M., Shlipak M. G., Serum cystatin C-versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. American Journal of Kidney Diseases 2012 60 922 929 10.1053/j.ajkd.2012.06.002
76. Conti M., Moutereau S., Zater M., Lallali K., Durrbach A., Manivet P., Eschwège P., Loric S., Urinary cystatin C as a specific marker of tubular dysfunction. Clinical Chemistry and Laboratory Medicine 2006 44 3 288 291 2-s2.0-33644828438 10.1515/CCLM.2006.050 (Pubitemid 43357687)
77. Uchida K., Gotoh A., Measurement of cystatin-C and creatinine in urine. Clinica Chimica Acta 2002 323 1-2 121 128 2-s2.0-0036065124 10.1016/S0009- 8981(02)00177-8 (Pubitemid 34804801)
78. Sirota J. C., Klawitter J., Edelstein C. L., Biomarkers of acute kidney injury. Journal of Toxicology 2011 2011 10 10.1155/2011/328120 328120
79. Nejat M., Hill J. V., Pickering J. W., Edelstein C. L., Devarajan P., Endre Z. H., Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrology Dialysis Transplantatio 2012 27 supplement 3 iii96 iii103 10.1093/ndt/gfr222
80. Nejat M., Pickering J. W., Walker R. J., Westhuyzen J., Shaw G. M., Frampton C. M., Endre Z. H., Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Critical Care 2010 14 3, article R85 2-s2.0-77951979657 10.1186/cc9014
81. Liangos O., Tighiouart H., Perianayagam M. C., Kolyada A., Han W. K., Wald R., Bonventre J. V., Jaber B. L., Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009 14 6 423 431 2-s2.0-70849091524 10.1080/ 13547500903067744
82. Koyner J. L., Vaidya V. S., Bennett M. R., Ma Q., Worcester E., Akhter S. A., Raman J., Jeevanandam V., O'Connor M. F., Devarajan P., Bonventre J. V., Murray P. T., Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clinical Journal of the American Society of Nephrology 2010 5 12 2154 2165 2-s2.0-78649658970 10.2215/CJN.00740110
83. Zhang Z., Lu B., Sheng X., Jin N., Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. American Journal of Kidney Diseases 2011 58 3 356 365 10.1053/j.ajkd.2011.02.389
84. Ichimura T., Bonventre J. V., Bailly V., Wei H., Hession C. A., Cate R. L., Sanicola M., Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Journal of Biological Chemistry 1998 273 7 4135 4142 2-s2.0-0032512724 10.1074/jbc.273.7.4135 (Pubitemid 28103282)
85. Han W. K., Bailly V., Abichandani R., Thadhani R., Bonventre J. V., Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney International 2002 62 1 237 244 2-s2.0-0036314217 10.1046/j.1523-1755.2002.00433.x (Pubitemid 34754067)
86. Ichimura T., Hung C. C., Yang S. A., Stevens J. L., Bonventre J. V., Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. American Journal of Physiology 2004 286 F552 F563 10.1152/ajprenal.00285.2002 (Pubitemid 38233650)
87. Vaidya V. S., Ramirez V., Ichimura T., Bobadilla N. A., Bonventre J. V., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. American Journal of Physiology-Renal Physiology 2006 290 2 F517 F529 2-s2.0-33644870877 10.1152/ajprenal.00291.2005 (Pubitemid 43725006)
88. Ichimura T., Asseldonk E. J. P. V., Humphreys B. D., Gunaratnam L., Duffield J. S., Bonventre J. V., Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. Journal of Clinical Investigation 2008 118 5 1657 1668 2-s2.0-43049125804 10.1172/JCI34487 (Pubitemid 351632370)
89. Liangos O., Perianayagam M. C., Vaidya V. S., Urinary N-acetyl-beta-(D)- glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology 2007 18 904 912 10.1681/ASN.2006030221 (Pubitemid 46434507)
90. Han W. K., Wagener G., Zhu Y., Wang S., Lee H. T., Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clinical Journal of the American Society of Nephrology 2009 4 5 873 882 2-s2.0-68049144273 10.2215/CJN.04810908
91. Melnikov V. Y., Ecder T., Fantuzzi G., Siegmund B., Lucia M. S., Dinarello C. A., Schrier R. W., Edelstein C. L., Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. Journal of Clinical Investigation 2001 107 9 1145 1152 2-s2.0-0035015397 (Pubitemid 32422911)
92. Edelstein C. L., Hoke T. S., Somerset H., Fang W., Klein C. L., Dinarello C. A., Faubel S., Proximal tubules from caspase-1-deficient mice are protected against hypoxia-induced membrane injury. Nephrology Dialysis Transplantation 2007 22 4 1052 1061 2-s2.0-34047161022 10.1093/ndt/gfl775 (Pubitemid 46523418)
93. Parikh C. R., Mishra J., Thiessen-Philbrook H., Dursun B., Ma Q., Kelly C., Dent C., Devarajan P., Edelstein C. L., Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney International 2006 70 1 199 203 2-s2.0-33745725903 10.1038/sj.ki.5001527 (Pubitemid 44000139)
94. Washburn K. K., Zappitelli M., Arikan A. A., Loftis L., Yalavarthy R., Parikh C. R., Edelstein C. L., Goldstein S. L., Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrology Dialysis Transplantation 2008 23 2 566 572 2-s2.0-43049122996 10.1093/ndt/gfm638 (Pubitemid 351767629)
95. Parikh C. R., Abraham E., Ancukiewicz M., Edelstein C. L., Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. Journal of the American Society of Nephrology 2005 16 10 3046 3052 2-s2.0-33644819168 10.1681/ASN.2005030236 (Pubitemid 44743502)
96. Siew E. D., Ikizler T. A., Gebretsadik T., Shintani A., Wickersham N., Bossert F., Peterson J. F., Parikh C. R., May A. K., Ware L. B., Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clinical Journal of the American Society of Nephrology 2010 5 8 1497 1505 2-s2.0-77955724098 10.2215/CJN.09061209
97. Wang G., Gong Y., Anderson J., Sun D., Minuk G., Roberts M. S., Burczynski F. J., Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2005 42 4 871 879 2-s2.0-25844523313 10.1002/hep.20857 (Pubitemid 41401125)
98. Ek-Von Mentzer B. A., Zhang F., Hamilton J. A., Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins: Implications for transmembrane and intracellular transport and for protection from lipid peroxidation. Journal of Biological Chemistry 2001 276 19 15575 15580 2-s2.0-0035844220 10.1074/jbc.M011623200
99. Oyama Y., Takeda T., Hama H., Tanuma A., Iino N., Sato K., Kaseda R., Ma M., Yamamoto T., Fujii H., Kazama J. J., Odani S., Terada Y., Mizuta K., Gejyo F., Saito A., Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Laboratory Investigation 2005 85 4 522 531 2-s2.0-20244383985 10.1038/labinvest.3700240 (Pubitemid 40523944)
100. Yamamoto T., Noiri E., Ono Y., Renal L-type fatty acid-binding protein in acute ischemic injury. Journal of the American Society of Nephrology 2007 18 2894 2902 10.1681/ASN.2007010097 (Pubitemid 350058396)
101. Doi K., Noiri E., Maeda-Mamiya R., Ishii T., Negishi K., Hamasaki Y., Fujita T., Yahagi N., Koide H., Sugaya T., Nakamura T., Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Critical Care Medicine 2010 38 10 2037 2042 2-s2.0-77957239451 10.1097/CCM.0b013e3181eedac0
102. Matsui K., Kamijo-Ikemori A., Hara M., Sugaya T., Kodama T., Fujitani S., Taira Y., Yasuda T., Kimura K., Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clinical and Experimental Nephrology 2011 15 2 220 225 2-s2.0-79959270411 10.1007/s10157-010-0384-y
103. Katagiri D., Doi K., Honda K., Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Annals of Thoracic Surgery 2012 93 2 577 583 10.1016/j.athoracsur.2011.10.048